Medical device testing and the constant momentum to automate
The tech industry in the U.S. has grown rapidly over the past ten to fifteen decades. But as more companies come to market with game-changing invention, there is also a substantial shortage of skilled assembly talent. The inability to always find high-quality assemblers is developing a roadblock for design, engineering, test, and production companies such as Benchmark, as well as to our clients. Without the proper meeting staff, the ability to deliver products to market quickly is hampered and new product introduction NPI, including product testing, can be significantly slowed. To meet market requirements, original equipment manufacturers are spending a lot of time seeking manufacturing partners with the maximum availability of talent. To serve our customers more efficiently and relieve the critical shortage of skilled labor, Benchmark aides our talent pool by implementing entirely – or semi-automated testing processes.
Using robotics and Automation has been an increasing tendency in factories around the world for several years. Automated procedures using robotics are climbing in use on production lines, transport centers, and manufacturing plants. The ability to automate repetitive procedures has created a more efficient and cost-effective go-to-market strategy for many OEMs. Medical device testing is a place Where we are especially seeing automation take hold and grow. With this highly regulated and complex industry, reducing human error with automation can mean the difference between failure or success in bringing the device to market. The proliferation of the miniaturisation of electronics in medical devices can also be creating situations where precision robotics is just better suited to the tasks required.
As this trend to automate more medical device testing processes progresses, there are numerous pros and cons to implementing automation which are important to comprehend. First of all, it can be a costly and time-consuming procedure. In the modern fast paced and competitive technology industry, most OEM’s are trying to find the fastest and most cost-effective testing procedure to receive their product to market. Determining return on investment ROI can also be tough. When we participate in a health test project using a new customer and product, it is tough to tell how many test or inspection stops the item will have. This makes it hard to compute the immediate and long-term effect of automation. Some organisations and product Development cycles would benefit from a fully- or – semi-automated test procedure upfront, while some might require more time to prepare before they implement it.